Documents
Study protocol
Initial protocol

16167_Xarelto_Protocol_Risk Minimization Study_Final_28Nov2011

English (1.66 MB - PDF) View document
Updated protocol

16167_Protocol_V4_Wave II_redacted

First published: 22/02/2024
English (1.69 MB - PDF) View document
Study results
Study results

16167_EU PAS Abstract_Redacted_V 1.0_2020-06-09

English (223.79 KB - PDF) View document
Study report
Study report

16167_Clinical Study Report_Wave III_redacted_V 1.0_2020-06-09

English (1.94 MB - PDF) View document

16167_Clinical Study Report_Wave II_redacted_V 1.0_ 2018-05-24

English (3.67 MB - PDF) View document

16167_Clinical Study Report_Wave I_redacted_V 1.0_2015-10-16

English (9.48 MB - PDF) View document

16167_progress report

English (119.93 KB - PDF) View document

RTI EUPAS3911 - Summary Interim Report

English (88.78 KB - PDF) View document
Other information
Study, other information

16167_Protocol_V2_Wave I_redacted

English (4.07 MB - PDF) View document

16167_Clinical Study Report_Wave II_redacted_V 1.0_ 2018-05-24.pdf

English (3.67 MB - PDF) View document

16167_Clinical Study Report_Wave I_redacted_V 1.0_2015-10-16.pdf

English (9.48 MB - PDF) View document

16167_progress report.pdf

English (119.93 KB - PDF) View document

RTI EUPAS3911 - Summary Interim Report.pdf

English (88.78 KB - PDF) View document